eChapters

A laboratory is essential for research work in science and development. Most of the research institutes have dedicated laboratories for researchers and students to conduct experiments, perform research work, as well as to provide hands-on learning/training to students. There are certain rules and regulations laid down by the laboratory in-charge which need to be followed strictly for safety purposes. Some of the laboratories keep ‘safety manual’ for researchers to read before entering into the laboratory to conduct experiments. Whenever safety is compromised in a laboratory, there is increase in risk of unwanted incidents in the laboratory. Storing food/beverages in the same refrigerator where laboratory chemicals are kept may lead to disastrous effects on health. This chapter aims to provide instructions in brief on the things to be performed (Do’s) before and after entering onto a laboratory as well as the things never to be done (Don’ts) in a laboratory for the safety reasons.

Good Laboratory Practices (Do’s)

• P Wear apron/labcoat while working in the laboratory.
• P Use gloves/respiratory mask/fumehood while handling toxic/volatile/inflammable chemicals/reagents.
• P Use pippet or pippetor for safety in transfer of solutions.
• P Protect eyes, face and naked parts of the body from UV radiations. Use safety goggles or face mask/apron.
• P Keep your eyes away from Liquid Nitrogen and use cryogloves while handling it.
• P Arrange all the necessary materials/solutions before starting the experiment.
• P Periodically fumigate/ozonize culture and inoculation rooms.
• P Autoclave all contaminated materials before discarding.
• P Pre-treat gel or solution containing Ethidium Bromide (EtBr) before discarding into laboratory waste-disposal bin, and use gloves while handling them.
• P Burn all the transgenic plant materials in an incinerator after taking necessary observations.
• P Make entry in the designated log-book and clean the instrument after using it properly.
• P Switch-off the instrument after use or when not in use.
• P Wash hands with soap and remove the labcoat before leaving/going out of the laboratory7.
• P Ensure that switches for fans/lights, and water taps are off while leaving the laboratory.
• P Follow the biosafety guidelines suggested for handling and disposal of the hazardous chemical.

Introduction
Antimicrobial resistance (AMR) represents one of the most significant public health challenges of modern times. The discovery of antibiotics in the early 20th century revolutionized medicine, transforming once-fatal infections into manageable conditions and enabling life-saving procedures such as organ transplantation, chemotherapy, and joint replacement surgery. However, the overuse and misuse of antibiotics in human medicine, veterinary practice, and agriculture have accelerated the development of resistant microorganisms. Today, infections caused by resistant pathogens claim millions of lives worldwide each year, with the World Health Organization warning of a postantibiotic era in which minor injuries or routine surgeries could again become life-threatening. Although AMR is often framed within the context of hospital-acquired infections and clinical treatment failure, its implications extend much further. In particular, AMR has significant consequences for physical and health fitness. For athletes, soldiers, patients in rehabilitation, and physically active individuals, resistant infections can disrupt performance, delay recovery, and compromise long-term health. The increasing prevalence of resistant organisms in community environments—including gyms, swimming pools, and sports facilities—further raises concern. This chapter situates AMR at the intersection of clinical medicine, sports science, and community health. It explores how resistant pathogens affect physically active populations, complicate rehabilitation processes, and influence outcomes in both competitive and recreational Fitnes. It also highlights the global and national responses to AMR, preventive strategies relevant to Fitnes and rehabilitation, and the role of healthcare professionals

Emerging Infectious Diseases
Emerging infectious diseases are those due to newly identified and previously unknown infections which cause public health problems either locally or internationally.
Re-emerging Infectious Diseases
Re-emerging infectious diseases are those due to the reappearance and increase of infections which are known, but had formerly fallen to levels so low that they were no longer considered a public health problem.
What Causes Emergence or Re-emergence of Infectious Diseases?
Several factors contribute to the emergence and re-emergence of infectious diseases, but most can be linked with the increasing number of people living and moving on earth: rapid and intense international travel; overcrowding in cities with poor sanitation; changes in handling and processing of large quantities of food; and increased exposure of humans to disease vectors and reservoirs in nature. Other factors include a deteriorating public health infrastructure which is unable to cope with population demands, and the emergence of resistance to antibiotics linked to their increased misuse.
Avian Influenza
Avian influenza is a zoonotic, globally important disease of birds that can be categorised as either low pathogenic (LPAI) or highly pathogenic (HPAI) according to the virulence of the virus in animals. Outbreaks of LPAI are common around the world but LPAI typically causes no clinical signs or only minor illness in infected birds. LPAI strains are generally less of a threat to human health; in addition, LPAI can have significant economic repercussions as a result of export restrictions and culling of birds, particularly in developing countries where the use of vaccines and other veterinary medicines is difficult
due to weak veterinarian services and small farming units. Compared with LPAI, HPAI is more readily detected in poultry due to very high levels of mortality in infected birds, and can cause potentially catastrophic economic consequences, from significantly reduced livestock populations to lost export markets. Though relatively rare, sporadic human infections of HPAI have occurred in cases of close contact with infected birds and caused serious illness
and even death.

Emerging Infectious Diseases
Emerging infectious diseases are those due to newly identified and previously unknown infections which cause public health problems either locally or internationally.
Re-emerging Infectious Diseases
Re-emerging infectious diseases are those due to the reappearance and increase of infections which are known, but had formerly fallen to levels so low that they were no longer considered a public health problem.
What Causes Emergence or Re-emergence of Infectious Diseases?
Several factors contribute to the emergence and re-emergence of infectious diseases, but most can be linked with the increasing number of people living and moving on earth: rapid and intense international travel; overcrowding in cities with poor sanitation; changes in handling and processing of large quantities of food; and increased exposure of humans to disease vectors and reservoirs in nature. Other factors include a deteriorating public health infrastructure which is unable to cope with population demands, and the emergence of resistance to antibiotics linked to their increased misuse.

Introduction
Antimicrobial resistance (AMR) is a critical public health problem globally, which can shake the foundation of modern healthcare. Infections caused by drugresistant organisms could lead to increased mortality and prolonged duration of hospitalization, causing a huge financial burden to the affected persons, healthcare systems and hinder the goals of sustainable development. With rising AMR, antibiotics are increasingly becoming ineffective for treating diseases.The post antibiotic era is not a dreadful imagination but a potential reality unless effective global actions are initiated now (1). AMR is not the only problem of human health, it widely affects the animal husbandry as well as environment. In India in 2019, there were 297,000 deaths attributable to AMR and 1,042,500 deaths associated with AMR. India has the 145th highest age-standardized mortality rate per 100,000 population associated with AMR across 204 countries.The number of AMR deaths in India is higher than deaths from neoplasms, respiratory infections and tuberculosis, enteric infections, diabetes and kidney diseases and maternal and neonatal disorders.Out of 10 million projected human deaths in 2050, one-fifth may be from India (2).Annually, more than 50 000 new-born are estimated to die from sepsis due to pathogens resistant to first-line antibiotics. The median cost of treatment of a resistant bacterial infection in India is estimated to be more than a year’s wages of a rural worker. There are five pathogens to be aware of in India (number of deaths associated with AMR in parenthesis): Escherichia coli (152,700), Klebsiella pneumoniae (123,200), Staphylococcus aureus (111,400), Acinetobacter baumannii (103,500), and Mycobacterium tuberculosis (98,600).If there is no timely containment, AMR is likely to cause nearly 10 million deaths by 2050 and resulting in significant economic losses. It would also impact nutrition security, livelihood and hinder the attainment of the Sustainable Development Goals. In 1928, penicillin was developed and socalled magic drug was subsequently commercialised and used globally. When antibiotic resistance ?rst emerged, novel antibiotics to treat these bacteria were developed. However, it is dif?cult to develop effective new antibiotics every time as it is time consuming and costly and if developed a new resistance mechanism emerges in bacteria. There is a demand for new strategies to treat bacterial infections, such as endophytes therapy, phage therapy, antimicrobial peptides, CRISPER cas and so on.

Mould growth in raw materials or finished feeds result in production of mycotoxins. Mycotoxins are a large group of toxic chemicals causing wide range of pathological and physiological effects in animals. Symptoms depend on the amount of toxin present in the feed, the period for which the feed is ingested, the nutritional status of the feed and the susceptibility of the animal. Feed efficiency, growth rate and production are affected in animals consuming sub-acute doses.

Ruminants are generally considered less susceptible to mycotoxins than monogastric animals because of degradation of mycotoxin in rumen by rumen microorganism. However, certain mycotoxins resist rumen degradation and cause clinical mycotoxicosis. In high yielding dairy animals, during transition period, animals who are in negative energy balance (NEB), low body condition score and decreased resistance to infectious agents cause adverse effects in animal health with exposure of mycotoxins present in animal diet.

Effect of mycotoxin in ruminants

In cattle during metabolism, mycotoxin present in stored or ensiled feeds produce microbial volatile organic compounds (MVOCs) which are responsible for mouldy odour, reduced feed intake and increased feeding times. This insufficient feed intake further produces negative energy balance (NEB).

K    :    Kilo (10³g).
 
K    :    Potassium.

KA    :    Ketoacidosis.

Karlvon Baer    :    Person who‚ in 1828‚ published on the developmental stages in mammalian eggs and showed that an undifferentiated‚ single-celled egg grows into a many-celled embryo.

Microorganisms live as single cells in nature in association with other cells in assemblage that we call “Population”. Such populations are composed of group of related cells generally derived by successive cell divisions from a single parent cell. The location in an environment where a population generally lives in association with other populations of cells called “Microbial communities”. Environmental microbiology deals with the study of these microbial communities in different habitats, naturally occurring on earth.

Natural habitats of microorganisms are exceedingly diverse. Any habitat that is suitable for the growth of microorganisms can also support the growth of other microorganisms. But in addition, there are many habitats where, extreme environment, due to chemical and physical factors, higher organisms cannot grow but microorganisms can grow and flourish. In this chapter, different habitats of microorganisms are discussed briefly.

Because microorganisms are so small, their habitats are also small. The term microenvironment is often used in ecology to describe where a microorganism actually lives and metabolites within its habitat.

This chapter deals with the principles and applications of serological tests used to detect antigens and antibodies. It distinguishes primary, secondary and tertiary binding tests and explains antibody titre, affinity, avidity, sensitivity and specificity. Important techniques include precipitation, agglutination, complement fixation, neutralization, immunofluorescence, ELISA, radioimmunoassay, Western blotting and the radioallergosorbent test. The chapter also addresses serum decomplementation and the interpretation of positive and negative reactions. These methods are central to the laboratory diagnosis, surveillance and control of infectious diseases. The objective questions enable readers to compare diagnostic techniques and select appropriate tests according to their principles, applications and analytical performance.

Cohn (1875) first observed and described a branching filamentous microorganism in the ‘concretions’ (coagulated mass) taken from a lacrimal canal, later identified as Actinomyces israelii. Bollinger first reported the yellow granules in jaw tissues of the cattle in 1877 and established the significance of the bacteria as the etiological agent. In 1878, Israel described the first human case. In 1879, Hartz observed the microscopic appearance of granules of Actinomyces and suggested the name Actinomyces bovis. Mosselman & Lihnaux (1890) and Wolf & Israel (1891) first isolated the bacteria in artificial laboratory media from lumpy jaw cases of cattle and human actinomycosis, respectively.

U    :    Units.

U&L    :    Upper and lower.

U&MNP    :    Ulnar and median nerve palsy.

U/O    :    Under observation for.
  
U/WB    :    Unit of whole blood.

UA    :    Umbilical artery; uric acid; urinalysis.
   
UC    :    Ulcerative colitis; unchanged; unconscious. 

Streptomyces are soil-borne bacteria known for production of several antibiotics, antifungals, antivirals, antitumoral, anti-hypertensives and immunosuppressives. Krainsky (1914) first described S. griseus and named the species Actinomyces griseus. Waksman and Henrici (1948) changed the name to Streptomyces griseus.

Dermatophilus congolensis was first described from clinical case of exudative dermatitis in cattle in Congo by Van Saceghem (1915). It is primarily known as an animal pathogen causing acute, sub acute or chronic skin disease. The first cases of human infection with D. congolensis were reported in 1961 in four people who developed skin infection after handling an infected deer in USA.

There are other groups that contribute to the reactivity of enzymes beside amino acid residues.

These groups are called cofactors - chemicals required by apoenzymes (inactive) to become holoenzymes (active).

There are two types of cofactors:

1. Essential ions - metal ions -inorganic
2. Coenzymes - organic molecules that act as group-transfer reagents (accept or donate groups)- can also be H⁺ and/or e^-

Both provide reactive groups not found on amino acids side chains.

Coenzymes can be either cosubstrates (loosely bound to enzyme; is altered, then regenerated) or prosthetic groups (tightly bound to enzyme).

Coenzymes can be classified by their source:

W    :    Watt.

W&D    :    Warm and dry.

W/A    :    Weakness atrophy.
    
W/C    :    Wheelchair.
    
W/E    :    Wound of entry.
    
W/U    :    Workup. 

X    :    Times; power; multiplied by.

Xenobiotic    :    Compound foreign to biological systems. Often refers to humanmade compounds that are resistant or recalcitrant to biodegradation and decomposition.